Impact of a chronic care model based on patient empowerment on the management of Type 2 diabetes: effects of the SINERGIA programme

Diabet. Med. 28, 724–730 (2011) Aims  Several chronic care models for diabetes have been implemented in Italy, although conclusive data on their effectiveness are lacking. In the Cusano‐Milanino diabetes clinic, patients with Type 2 diabetes with a stable disease/therapy (i.e. a steady level of HbA1...

Full description

Saved in:
Bibliographic Details
Published in:Diabetic medicine Vol. 28; no. 6; pp. 724 - 730
Main Authors: Musacchio, N., Lovagnini Scher, A., Giancaterini, A., Pessina, L., Salis, G., Schivalocchi, F., Nicolucci, A., Pellegrini, F., Rossi, M. C. E.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-06-2011
Blackwell
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diabet. Med. 28, 724–730 (2011) Aims  Several chronic care models for diabetes have been implemented in Italy, although conclusive data on their effectiveness are lacking. In the Cusano‐Milanino diabetes clinic, patients with Type 2 diabetes with a stable disease/therapy (i.e. a steady level of HbA1c without need for therapy changes) are included in the SINERGIA programme: diabetologists, nurses and dietitians empower patients and telemedicine resources are utilized efficiently. Methods  Clinical outcomes measured in the year before and after the initiation of SINERGIA were compared. A generalized hierarchical linear regression model for repeated measures was used. Results  Altogether, 1004 patients were included; baseline characteristics were (mean ± sd): age 66.6 ± 6.2 years, 54.1% male, diabetes duration 10.8 ± 7.7 years, BMI 29.5 ± 4.8 kg/m2, HbA1c 6.9 ± 0.9% (52 ± 14 mmol/mol); 72.9% of patients were treated with anti‐hypertensive drugs; 32.7% were treated with lipid‐lowering drugs. After a median follow‐up of 12 months (range 6–24 months), the proportion of patients with HbA1c≤ 7.0% (≤ 53 mmol/mol) increased from 32.7 to 45.8% (P < 0.0001), while those with HbA1c≥ 9% (≥ 75 mmol/mol) decreased from 10.5 to 4.3% (P < 0.0001). Patients with LDL cholesterol < 100 mg/dl (< 2.59 mmol/l) increased from 40 to 47% (P < 0.0001), while those with LDL cholesterol ≥ 130 mg/dl (≥ 3.36 mmol/l) decreased from 26.6 to 19.7%; blood pressure levels were slightly improved. The mean number of face‐to‐face encounters decreased from (median and range) 2.8 (2.3–3.4) to 2.3 (1.9–2.7) (P < 0.0001) visits per patient/year. Conclusions  The SINERGIA model is effective in improving metabolic control and major cardiovascular risk factors, while allowing diabetologists to dedicate more time to patients with more acute disease.
Bibliography:ark:/67375/WNG-CRL2FTCX-M
ArticleID:DME3253
istex:E3B1D5F55BDDCE0618097E83D7A9D02E10A60870
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0742-3071
1464-5491
DOI:10.1111/j.1464-5491.2011.03253.x